Multiple sclerosis is a disease that results when the immune system mistakenly attacks the brain and spinal cord. It affects ...
Revisions made in 2024 to the McDonald criteria allowed for the diagnosis of multiple sclerosis in a small cohort of ...
Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...
For the first time, researchers have identified that inflammation—long associated with multiple sclerosis (MS)—appears to ...